397 related articles for article (PubMed ID: 27909742)
21. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
Mohamed MZ; Zenhom NM
Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
[TBL] [Abstract][Full Text] [Related]
22. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
23. Montelukast exerts no acute direct effect on NO synthases.
Hamacher J; Eichert K; Braun C; Grebe T; Strub A; Lucas R; Eltze M; Wendel A
Pulm Pharmacol Ther; 2007; 20(5):525-33. PubMed ID: 16815057
[TBL] [Abstract][Full Text] [Related]
24. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying the protective effect of montelukast in prevention of endometrial hyperplasia in female rats.
Abdelzaher WY; Bahaa HA; Toni NDM; Sanad AS
Int Immunopharmacol; 2018 Sep; 62():326-333. PubMed ID: 30056375
[TBL] [Abstract][Full Text] [Related]
26. A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis.
Sugimoto M; Zhang X; Ueda N; Tsunemori H; Taoka R; Hayashida Y; Hirama H; Miyauchi Y; Matsuoka Y; Naito H; Osaki Y; Kekehi Y
BMC Urol; 2019 Oct; 19(1):99. PubMed ID: 31646996
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
28. Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.
Ozkan E; Akyüz C; Sehirli AO; Topaloğlu U; Ercan F; Sener G
Pancreas; 2010 Oct; 39(7):1041-6. PubMed ID: 20467345
[TBL] [Abstract][Full Text] [Related]
29. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
30. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
31. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
[TBL] [Abstract][Full Text] [Related]
32. Bladder function in 17β-estradiol-induced nonbacterial prostatitis model in Wistar rat.
Matsumoto S; Kawai Y; Oka M; Oyama T; Hashizume K; Wada N; Hori J; Tamaki G; Kita M; Iwata T; Kakizaki H
Int Urol Nephrol; 2013 Jun; 45(3):749-54. PubMed ID: 23616059
[TBL] [Abstract][Full Text] [Related]
33. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
34. Cysteinyl leukotriene receptor antagonism: a promising pharmacological strategy for lowering the severity of arthritis.
Venugopal N; Acharya P; Zarei M; Talahalli RR
Inflammopharmacology; 2019 Oct; 27(5):923-931. PubMed ID: 31309487
[TBL] [Abstract][Full Text] [Related]
35. Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate.
Taniguchi S; Taoka R; Inui M; Sugimoto M; Kakehi Y
Urology; 2009 Feb; 73(2):410-4. PubMed ID: 18929399
[TBL] [Abstract][Full Text] [Related]
36. Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
Di Gennaro A; Araújo AC; Busch A; Jin H; Wågsäter D; Vorkapic E; Caidahl K; Eriksson P; Samuelsson B; Maegdefessel L; Haeggström JZ
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1907-1912. PubMed ID: 29432192
[TBL] [Abstract][Full Text] [Related]
37. Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats.
Kim DS; Lee EJ; Cho KS; Yoon SJ; Lee YH; Hong SJ
Yonsei Med J; 2009 Jun; 50(3):391-8. PubMed ID: 19568602
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
39. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
40. Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects.
Mansour RM; Ahmed MAE; El-Sahar AE; El Sayed NS
Toxicol Appl Pharmacol; 2018 Nov; 358():76-85. PubMed ID: 30222980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
